Fig. 3From: Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patientsCorrelations of P4HB with prognosis and radiotherapy resistance. a Kaplan–Meier curve showing the survival differences of high and low P4HB expression in the TCGA database; b Kaplan–Meier curve showing the survival differences of high and low P4HB expression in patients with N0 stage; c Kaplan–Meier curve showing the survival differences of high and low P4HB expression in White patients; d Kaplan–Meier curve showing the survival differences of high and low P4HB expression in patients with residual tumor; e Kaplan–Meier curve showing the survival differences of high and low P4HB expression in patients with age < 60 years; f Kaplan–Meier curve showing the survival differences of high and low P4HB expression in patients with overlapping or multiple zones; g nomogram plot integrating P4HB expression and clinical featurs; h decision curve analysis curve; i ROC curve showing the diagnostic ability of P4HB in radiotherapy resistance. TCGA the cancer genome atlas, ROC receiver operating characteristic curveBack to article page